Patents by Inventor Andrew Main

Andrew Main has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240060075
    Abstract: Provided herein are compositions and methods for producing myrcene by culturing genetically modified microbial host cells that express a myrcene synthase and optionally a geranyl pyroplosphate synthase. Also provided herein are isolated nucleic acid molecules that encode myrcene synthase variants derived from the Ocimum species myrcene synthase, which comprise one or more amino acid substitutions that improve in vivo performance of myrcene synthase in genetically modified microbial host cells. Also provided herein are isolated myrcene synthase variants that exhibit an improved activity for converting geranyl diphosphate into myrcene.
    Type: Application
    Filed: August 23, 2023
    Publication date: February 22, 2024
    Inventors: Andrew MAIN, Grzegorz WOJCIECHOWSKI, Yue YANG, Lishan ZHAO
  • Patent number: 11767533
    Abstract: Provided herein are compositions and methods for producing myrcene by culturing genetically modified microbial host cells that express a myrcene synthase and optionally a geranyl pyroplosphate synthase. Also provided herein are isolated nucleic acid molecules that encode myrcene synthase variants derived from the Ocimum species myrcene synthase, which comprise one or more amino acid substitutions that improve in vivo performance of myrcene synthase in genetically modified microbial host cells. Also provided herein are isolated myrcene synthase variants that exhibit an improved activity for converting geranyl diphosphate into myrcene.
    Type: Grant
    Filed: July 9, 2021
    Date of Patent: September 26, 2023
    Assignee: AMYRIS, INC.
    Inventors: Andrew Main, Grzegorz Wojciechowski, Yue Yang, Lishan Zhao
  • Publication number: 20220251606
    Abstract: Provided herein are compositions and methods of integrating one or more exogenous donor nucleic acids into one or more exogenous landing pads engineered into a host cell's genome. In certain embodiments, the exogenous landing pads and exogenous donor nucleic acids comprise standardized, compatible homology regions so that exogenous donor nucleic acids can integrate into any of the landing pads, independent of the genomic sequences surrounding the landing pads. In certain embodiments, the methods comprise contacting the host cell comprising landing pads with one or more exogenous donor nucleic acids, and a nuclease capable of causing a double-strand break within the landing pads, and recovering a host cell comprising one or more exogenous donor nucleic acids integrated in any of the landing pads.
    Type: Application
    Filed: March 9, 2022
    Publication date: August 11, 2022
    Inventors: Kevin GEORGE, Andrew MAIN, Chia-Hong TSAI
  • Patent number: 11293033
    Abstract: Provided herein are compositions and methods of integrating one or more exogenous donor nucleic acids into one or more exogenous landing pads engineered into a host cell's genome. In certain embodiments, the exogenous landing pads and exogenous donor nucleic acids comprise standardized, compatible homology regions so that exogenous donor nucleic acids can integrate into any of the landing pads, independent of the genomic sequences surrounding the landing pads. In certain embodiments, the methods comprise contacting the host cell comprising landing pads with one or more exogenous donor nucleic acids, and a nuclease capable of causing a double-strand break within the landing pads, and recovering a host cell comprising one or more exogenous donor nucleic acids integrated in any of the landing pads.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: April 5, 2022
    Assignee: AMYRIS, INC.
    Inventors: Kevin George, Andrew Main, Chia-Hong Tsai
  • Publication number: 20220002735
    Abstract: Provided herein are compositions and methods for producing myrcene by culturing genetically modified microbial host cells that express a myrcene synthase and optionally a geranyl pyroplosphate synthase. Also provided herein are isolated nucleic acid molecules that encode myrcene synthase variants derived from the Ocimum species myrcene synthase, which comprise one or more amino acid substitutions that improve in vivo performance of myrcene synthase in genetically modified microbial host cells. Also provided herein are isolated myrcene synthase variants that exhibit an improved activity for converting geranyl diphosphate into myrcene.
    Type: Application
    Filed: July 9, 2021
    Publication date: January 6, 2022
    Inventors: Andrew MAIN, Grzegorz WOJCIECHOWSKI, Yue YANG, Lishan ZHAO
  • Patent number: 11085046
    Abstract: Provided herein are compositions and methods for producing myrcene by culturing genetically modified microbial host cells that express a myrcene synthase and optionally a geranyl pyrophosphate synthase. Also provided herein are isolated nucleic acid molecules that encode myrcene synthase variants derived from the Ocimum species myrcene synthase, which comprise one or more amino acid substitutions that improve in vivo performance of myrcene synthase in genetically modified microbial host cells. Also provided herein are isolated myrcene synthase variants that exhibit an improved activity for converting geranyl diphosphate into myrcene.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: August 10, 2021
    Assignee: AMYRIS, INC.
    Inventors: Andrew Main, Grzegorz Wojciechowski, Yue Yang, Lishan Zhao
  • Publication number: 20200200942
    Abstract: A downhole logging tool includes a tool body housing an opto-electronics assembly. The opto-electronics assembly includes a circuit board and an opto-electronics module coupled to the circuit board and receiving control signals from the circuit board. The opto-electronics module includes a light source, a reference detector, a measurement detector, and a first beam splitter positioned with respect to the light source and the reference detector. The first beam splitter directs a first portion of light emitted from the light source into the reference detector and a second portion of the light emitted from the light source into an optical conduit. The opto-electronics module also includes a second beam splitter positioned with respect to the optical conduit and the measurement detector. The second beam splitter directs at least a portion of light received from the optical conduit into the measurement detector.
    Type: Application
    Filed: December 19, 2019
    Publication date: June 25, 2020
    Applicant: Baker Hughes Oilfield Operations LLC
    Inventors: Andrew Main, Stephen Day, Ian Davidson, James David Ratcliffe
  • Patent number: 10653449
    Abstract: A surgical access device comprises a seal assembly (51) having a plurality of part circular sealing members (55) each attached to a common ring (53) which is held within the device about its longitudinal axis. In use, the sealing members are located radially inwards of the ring in a stacked relationship. When not within the device, the sealing members are movable from a position radially outwards of the ring to a position radially inwards of the ring. A seal core comprises the seal assembly and a protective member which, in use, is located on the proximal side of the seal assembly. A method of assembling the surgical access device is also provided.
    Type: Grant
    Filed: January 11, 2016
    Date of Patent: May 19, 2020
    Assignee: SURGICAL INNOVATIONS LIMITED
    Inventors: David Andrew Main, Christopher David Harrison
  • Publication number: 20190382773
    Abstract: Provided herein are compositions and methods for producing myrcene by culturing genetically modified microbial host cells that express a myrcene synthase and optionally a geranyl pyrophosphate synthase. Also provided herein are isolated nude is acid molecules that encode myrcene synthase variants derived from the Ocimum species myrcene synthase, which comprise one or more amino acid substitutions that improve in vivo performance of myrcene synthase in genetically modified microbial host cells. Also provided herein are isolated myrcene synthase variants that exhibit an improved activity for converting geranyl diphosphate into myrcene.
    Type: Application
    Filed: October 28, 2016
    Publication date: December 19, 2019
    Inventors: Andrew MAIN, Grzegorz WOJCIECHOWSKI, Yue YANG, Lishan ZHAO
  • Publication number: 20190144887
    Abstract: Provided herein are compositions and methods of integrating one or more exogenous donor nucleic acids into one or more exogenous landing pads engineered into a host cell's genome. In certain embodiments, the exogenous landing pads and exogenous donor nucleic acids comprise standardized, compatible homology regions so that exogenous donor nucleic acids can integrate into any of the landing pads, independent of the genomic sequences surrounding the landing pads. In certain embodiments, the methods comprise contacting the host cell comprising landing pads with one or more exogenous donor nucleic acids, and a nuclease capable of causing a double-strand break within the landing pads, and recovering a host cell comprising one or more exogenous donor nucleic acids integrated in any of the landing pads.
    Type: Application
    Filed: May 18, 2017
    Publication date: May 16, 2019
    Inventors: Kevin GEORGE, Andrew MAIN, Chia-Hong TSAI
  • Publication number: 20180338778
    Abstract: An obturator includes an elongate shaft extending between a proximal end and a distal end, the elongate shaft having an opening at the proximal end and defining an elongate cavity which is sized and shaped to receive an optical instrument. The obturator is provided with an axially extending finger for radial movement inwardly to engage the outer surface of the optical instrument located within the elongate cavity. The finger may be a latch member with a latch element and able to be moved between a first position, in which the latch element is located relatively radially inward, and a second position in which the latch element is located relatively radially outward. With the obturator located within a cannula body, an instrument inserted into the obturator causes the latch element of the latch member to engage with the cannula to prevent relative axial movement therebetween.
    Type: Application
    Filed: December 22, 2016
    Publication date: November 29, 2018
    Applicant: Surgical Innovations Limited
    Inventors: David Andrew Main, Christopher David Harrison
  • Publication number: 20180021063
    Abstract: A surgical access device comprises a seal assembly (51) having a plurality of part circular sealing members (55) each attached to a common ring (53) which is held within the device about its longitudinal axis. In use, the sealing members are located radially inwards of the ring in a stacked relationship. When not within the device, the sealing members are movable from a position radially outwards of the ring to a position radially inwards of the ring. A seal core comprises the seal assembly and a protective member which, in use, is located on the proximal side of the seal assembly. A method of assembling the surgical access device is also provided.
    Type: Application
    Filed: January 11, 2016
    Publication date: January 25, 2018
    Applicant: SURGICAL INNOVATIONS LIMITED
    Inventors: David Andrew MAIN, Christopher David HARRISON
  • Publication number: 20120270260
    Abstract: The present disclosure relates to methods of developing terpene synthase variants through engineered host cells. Particularly, the disclosure provides methods of developing terpene synthase variants with improved in vivo performance that are useful in the commercial production of terpene products. Further encompassed in the present disclosure are superior terpene synthase variants and host cells comprising such terpene synthase variants.
    Type: Application
    Filed: July 5, 2012
    Publication date: October 25, 2012
    Applicant: AMYRIS, INC.
    Inventors: Lishan Zhao, Lan Xu, Patrick Westfall, Andrew Main
  • Patent number: 8236512
    Abstract: The present disclosure relates to methods of developing terpene synthase variants through engineered host cells. Particularly, the disclosure provides methods of developing terpene synthase variants with improved in vivo performance that are useful in the commercial production of terpene products. Further encompassed in the present disclosure are superior terpene synthase variants and host cells comprising such terpene synthase variants.
    Type: Grant
    Filed: February 1, 2012
    Date of Patent: August 7, 2012
    Assignee: Amyris, Inc.
    Inventors: Lishan Zhao, Lan Xu, Patrick Westfall, Andrew Main
  • Publication number: 20120196315
    Abstract: The present disclosure relates to methods of developing terpene synthase variants through engineered host cells. Particularly, the disclosure provides methods of developing terpene synthase variants with improved in vivo performance that are useful in the commercial production of terpene products. Further encompassed in the present disclosure are superior terpene synthase variants and host cells comprising such terpene synthase variants.
    Type: Application
    Filed: February 1, 2012
    Publication date: August 2, 2012
    Applicant: AMYRIS, INC.
    Inventors: Lishan Zhao, Lan Xu, Patrick Westfall, Andrew Main